Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Role of PD-1 as an immunotherapeutic target in GI cancers
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Role of PD-1 as an immunotherapeutic target in GI cancers'. Together they form a unique fingerprint.
Digestive System Cancer
Pharmacology, Toxicology and Pharmaceutical Science
100%
Immunotherapy
Immunology and Microbiology
100%
PD-L1
Biochemistry, Genetics and Molecular Biology
100%
Immune Checkpoint Inhibitor
Biochemistry, Genetics and Molecular Biology
100%
Programmed Death-Ligand 1
Immunology and Microbiology
66%
Malignant Neoplasm
Pharmacology, Toxicology and Pharmaceutical Science
16%
Solid Malignant Neoplasm
Pharmacology, Toxicology and Pharmaceutical Science
16%
Metastatic Melanoma
Pharmacology, Toxicology and Pharmaceutical Science
16%
Cite this